References
- Giudice LC, Kao LC. Endometriosis. Lancet 2004;364:1789–99
- Berkley KJ, Rapkin AJ, Papka RE. The pains of endometriosis. Science 2005;308:587–9
- Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am 1997;24:235–58
- Kennedy S, Mardon H, Barlow D. Familial endometriosis. J Assist Reprod Genet 1995;12:32–4
- Simpson JL, Bischoff FZ. Heritability and molecular genetic studies of endometriosis. Ann N Y Acad Sci 2002;955:239–51; discussion 93–5, 396–406
- Montgomery GW, Nyholt DR, Zhao ZZ, et al. The search for genes contributing to endometriosis risk. Hum Reprod Update 2008;14:447–57
- Keenan JA, Chen TT, Chadwell NL, et al. IL-1 beta, TNF-alpha, and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis. Am J Reprod Immunol 1995;34:381–5
- Braun DP, Gebel H, House R, et al. Spontaneous and induced synthesis of cytokines by peripheral blood monocytes in patients with endometriosis. Fertil Steril 1996;65:1125–9
- Asghar T, Yoshida S, Kennedy S, et al. The tumor necrosis factor-alpha promoter −1031C polymorphism is associated with decreased risk of endometriosis in a Japanese population. Hum Reprod 2004;19:2509–14
- McLaren J. Vascular endothelial growth factor and endometriotic angiogenesis. Hum Reprod Update 2000;6:45–55
- Bhanoori M, Arvind Babu K, Pavankumar Reddy NG, et al. The vascular endothelial growth factor (VEGF) + 405G > C 5′-untranslated region polymorphism and increased risk of endometriosis in South Indian women: a case control study. Hum Reprod 2005;20:1844–9
- Kim SH, Choi YM, Choung SH, et al. Vascular endothelial growth factor gene +405 C/G polymorphism is associated with susceptibility to advanced stage endometriosis. Hum Reprod 2005;20:2904–8
- Zondervan KT, Cardon LR, Kennedy SH. What makes a good case-control study? Design issues for complex traits such as endometriosis. Hum Reprod 2002;17:1415–23
- Tempfer CB, Simoni M, Destenaves B, Fauser BC. Functional genetic polymorphisms and female reproductive disorders: part II-endometriosis. Hum Reprod Update 2009;15:97–118
- Agic A, Xu H, Finas D, et al. Is endometriosis associated with systemic subclinical inflammation? Gynecol Obstet Invest 2006;62:139–47
- Hsieh YY, Chang CC, Tsai FJ, et al. Polymorphisms for interleukin-4 (IL-4) −590 promoter, IL-4 intron3, and tumor necrosis factor alpha −308 promoter: non-association with endometriosis. J Clin Lab Anal 2002;16:121–6
- Lee MK, Park AJ, Kim DH. Tumor necrosis factor-alpha and interleukin-6 promoter gene polymorphisms are not associated with an increased risk of endometriosis. Fertil Steril 2002;77:1304–5
- Wieser F, Fabjani G, Tempfer C, et al. Tumor necrosis factor-alpha promoter polymorphisms and endometriosis. J Soc Gynecol Investig 2002;9:313-8
- Teramoto M, Kitawaki J, Koshiba H, et al. Genetic contribution of tumor necrosis factor (TNF)-alpha gene promoter (−1031, −863 and −857) and TNF receptor 2 gene polymorphisms in endometriosis susceptibility. Am J Reprod Immunol 2004;51:352–7
- Zhao ZZ, Nyholt DR, Le L, et al. Genetic variation in tumour necrosis factor and lymphotoxin is not associated with endometriosis in an Australian sample. Hum Reprod 2007;22:2389–97
- Ikuhashi Y, Yoshida S, Kennedy S, et al. Vascular endothelial growth factor +936 C/T polymorphism is associated with an increased risk of endometriosis in a Japanese population. Acta Obstet Gynecol Scand 2007;86:1352–8
- Gentilini D, Somigliana E, Vigano P, et al. The vascular endothelial growth factor +405G > C polymorphism in endometriosis. Hum Reprod 2008;23:211–5
- Emamifar B, Salehi Z, Mehrafza M, Mashayekhi F. The vascular endothelial growth factor (VEGF) polymorphisms and the risk of endometriosis in northern Iran. Gynecol Endocrinol 2012;28:447–50
- Liang S, Huang Y, Fan Y. Vascular endothelial growth factor gene polymorphisms and endometriosis risk: a meta-analysis. Arch Gynecol Obstet 2012;286:139–46